✦ LIBER ✦
Alemtuzumab as first-line therapy for B-cell chronic lymphocytic leukemia: long-term follow-up of clinical effects, infectious complications and risk of Richter transformation
✍ Scribed by Karlsson, C; Norin, S; Kimby, E; Sander, B; Porwit MacDonald, A; Nilsson, B; Johansson, E; Mellstedt, H; Lundin, J; Österborg, A
- Book ID
- 110056951
- Publisher
- Nature Publishing Group
- Year
- 2006
- Tongue
- English
- Weight
- 103 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0887-6924
No coin nor oath required. For personal study only.